The Prescription Drug User Fee Act (PDUFA) for lofexidine is May 26; FDA actions on new drug applications often occur at near the PDUFA date.
The FDA is not obligated to follow the recommendations of its advisory committees.
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.